Marvell's $80B Target: A Multibagger in the Making?
💡 Key Takeaway
Marvell's ambitious fiscal 2031 revenue target of $80 billion, backed by deep partnerships with Alphabet and Nvidia, suggests the stock could triple by 2031, making it a compelling AI infrastructure play.
Marvell's Bold 2031 Vision: $80 Billion Revenue
At its 2026 Investor Day, Marvell Technology (MRVL) set a stunning long-term revenue target: $70 billion to $90 billion by fiscal 2031. At the midpoint, that's nearly 10 times the $8.2 billion in sales the company generated in fiscal 2026. Wall Street had been expecting less than $50 billion, so this forecast caught many off guard.
The optimism is rooted in the AI infrastructure boom. Marvell estimates its total addressable market (TAM) across data centers and communications will grow at a 45% compound annual growth rate (CAGR) through 2030, reaching $400 billion. The company's revenue forecast breaks down into four key categories: interconnect, switching and storage, custom chips, and communications. The custom chip segment, which includes custom AI accelerators, is expected to grow at a 75% to 85% CAGR, reaching $30 billion in revenue.
Marvell's confidence is bolstered by powerful partnerships. With Alphabet, Marvell is collaborating on custom chips for Google's Tensor Processing Unit (TPU) ecosystem, with potential purchasing commitments reaching $120 billion through fiscal 2033. Nvidia also invested $2 billion in Marvell earlier this year as part of an expanded partnership around NVLink Fusion, where Marvell will provide custom XPUs and networking solutions. Nvidia estimates the NVLink Fusion opportunity could reach $250 billion annually by the end of the decade.
Management also raised its fiscal 2028 revenue target from $18 billion to $20 billion, well above Wall Street's $18.2 billion estimate. The company expects to earn $30-plus per share if it hits $80 billion in revenue. Based on these projections, a $10,000 investment in Marvell today could grow to approximately $23,500 to $32,000 by fiscal 2031, assuming some valuation compression.
Why Marvell's Forecast Changes the Game
Marvell's new forecast significantly outpaces Wall Street's expectations, signaling that the company is positioning itself as a major player in the AI infrastructure buildout. If management delivers even close to its targets, the stock could see substantial upside from current levels. The projected revenue CAGR of 55% to 60% through fiscal 2031 is exceptional for a company of Marvell's size.
The partnerships with Alphabet and Nvidia are critical. Alphabet's purchasing commitments could reach $120 billion, providing a massive revenue stream for Marvell's custom chip business. Nvidia's investment and collaboration on NVLink Fusion not only validate Marvell's technology but also open up a $250 billion annual opportunity in AI factories. These relationships give Marvell a competitive edge and reduce the risk of its ambitious targets.
However, the stock already trades at a premium valuation, and execution risks remain. The semiconductor industry is cyclical, and competition is fierce. Companies like Broadcom and AMD are also vying for AI chip market share. Marvell's ability to scale its custom chip business and maintain its technological leadership will be key.
For investors, the potential reward is significant, but so is the risk. If Marvell hits its targets, the stock could triple by 2031. But any misstep could lead to a sharp correction, given the high expectations baked into the current price.
Source: The Motley Fool
Analysis generated by Bobby AI quantitative model, reviewed and edited by our research team. This is not financial advice. Always do your own research before making investment decisions.
Bobby Insight

Buy Marvell for the long term, as its AI-driven growth story and strategic partnerships could deliver multibagger returns by 2031.
Marvell's raised guidance and deep partnerships with Alphabet and Nvidia provide strong visibility into future revenue. The stock's premium valuation is justified by its massive growth potential, and any pullback should be seen as a buying opportunity for patient investors.
What This Means for Me


